Naunyn-Schmiedeberg s Archives of Pharmacology, Journal Year: 2024, Volume and Issue: unknown
Published: Dec. 16, 2024
Language: Английский
Naunyn-Schmiedeberg s Archives of Pharmacology, Journal Year: 2024, Volume and Issue: unknown
Published: Dec. 16, 2024
Language: Английский
Metabolism and Target Organ Damage, Journal Year: 2025, Volume and Issue: 5(1)
Published: Jan. 25, 2025
An imbalance in the metabolism of glycolipids largely causes numerous metabolic diseases that negatively affect human health. Metrnl plays an important role glycolipid and regulates glucose lipid through multiple mechanisms. However, expression level related to remains controversial. can increase utilization by tissue cells reduce adverse effects a high-glucose environment on body; metabolism, it composition blood lipids, accumulation fat, promote browning white fat. The clinical efficacy exogenously administered recombinant needs be further investigated verified. This review presents overview Metrnl, emphasizing its association with diseases. It offers theoretical foundation for treatment metabolism-related conditions.
Language: Английский
Citations
0Metabolism and Target Organ Damage, Journal Year: 2024, Volume and Issue: 4(4)
Published: Dec. 9, 2024
Language: Английский
Citations
0Naunyn-Schmiedeberg s Archives of Pharmacology, Journal Year: 2024, Volume and Issue: unknown
Published: Dec. 16, 2024
Language: Английский
Citations
0